Boaz Tal, the General Counsel of $NBIS, sold 3,036 shares of the company on 03-31-2026 for an estimated $299,882. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.4% of their shares of this class of stock. Following this trade, they now own 85,854 shares of this class of $NBIS stock.
$NBIS Insider Trading Activity
$NBIS insiders have traded $NBIS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NBIS stock by insiders over the last 6 months:
- BOAZ TAL (General Counsel) sold 3,036 shares for an estimated $299,882
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NBIS Hedge Fund Activity
We have seen 366 institutional investors add shares of $NBIS stock to their portfolio, and 279 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIS ALLAN GRAY LTD removed 9,461,185 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $791,948,490
- BLACKROCK, INC. added 9,407,534 shares (+39418.1%) to their portfolio in Q4 2025, for an estimated $787,457,633
- JERICHO CAPITAL ASSET MANAGEMENT L.P. removed 4,607,497 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $385,670,536
- STATE STREET CORP added 3,090,103 shares (+2391.3%) to their portfolio in Q4 2025, for an estimated $258,657,071
- CAPITAL RESEARCH GLOBAL INVESTORS added 2,767,280 shares (+inf%) to their portfolio in Q4 2025, for an estimated $231,635,172
- WELLS FARGO & COMPANY/MN removed 2,379,259 shares (-93.6%) from their portfolio in Q4 2025, for an estimated $199,155,874
- TWO SIGMA INVESTMENTS, LP removed 2,321,469 shares (-96.3%) from their portfolio in Q4 2025, for an estimated $194,318,562
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NBIS Analyst Ratings
Wall Street analysts have issued reports on $NBIS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/19/2025
- BWS Financial issued a "Buy" rating on 11/13/2025
- CICC issued a "Outperform" rating on 11/11/2025
To track analyst ratings and price targets for $NBIS, check out Quiver Quantitative's $NBIS forecast page.
$NBIS Price Targets
Multiple analysts have issued price targets for $NBIS recently. We have seen 9 analysts offer price targets for $NBIS in the last 6 months, with a median target of $169.0.
Here are some recent targets:
- Tal Liani from B of A Securities set a target price of $150.0 on 03/24/2026
- Tyler Radke from Citigroup set a target price of $169.0 on 03/16/2026
- Alex Platt from DA Davidson set a target price of $200.0 on 03/16/2026
- Hamed Khorsand from BWS Financial set a target price of $200.0 on 03/16/2026
- Michael Donovan from Compass Point set a target price of $150.0 on 02/18/2026
- Josh Baer from Morgan Stanley set a target price of $126.0 on 01/15/2026
- Greg Miller from Citizens set a target price of $175.0 on 11/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
